C.R. Bard IVC Filter Lawsuit Filings Mount, As Cases Pending in Federal Multidistrict Litigation Double, Bernstein Liebhard LLP Reports

September 22, 2015 - C.R. Bard, Inc. faces a growing number of IVC filter lawsuits (http://www.ivcfilterlawsuit2015.com/) involving its Recovery and G2 devices. According to an updated docket report issued on September 15th by the U.S. Judicial Panel on Multidistrict (JPML), at least 50 claims were pending in the centralized proceeding now underway in the U.S. District Court, District of Arizona. Just 22 cases were initially transferred to Arizona last month, when the JPML created the Bard IVC filter litigation. (In Re: Bard IVC Filters Products Liability Litigation – MDL No. 2641)

"Our Firm has heard from a number of individuals who allegedly suffered serious complications following the fracture or migration of a Bard Recovery or G2 IVC filter. It is not surprising that the litigation surrounding these devices is growing at a fairly rapid rate," says Sandy A. Liebhard LLP, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently investigating product liability claims on behalf of individuals who may have been harmed by C.R. Bard's IVC filters.

C.R. Bard IVC Filter Lawsuits
C.R. Bard's Recovery and IVC filter lawsuits were designed for implantation in the inferior vena cava, so as to "catch" blood clots before they travel to the lungs and become a pulmonary embolism. The retrievable filters are intended to be removed once a patient is no longer at risk for blood clots, but a study published by JAMA Internal Medicine in March 2013 indicated that only 10% of IVC filters are successfully retrieved. The same study also found that around 8% of IVC filter patients experienced a pulmonary embolism, despite the presence of the filter.

In 2010, the U.S. Food & Drug Administration (FDA) disclosed that retrievable IVC filters had been associated with more than 900 adverse events, including incidents of migration, fracture and embolization, and perforation of the inferior vena cava. In 2014, the agency issued a new advisory to remind doctors that retrievable IVC filters should be removed within 29 to 54 days of their implantation.

The IVC filter lawsuits pending in the C.R. Bard litigation all put forth similar allegations regarding the propensity of the Recovery and G2 devices to fracture, migrate, tilt or perforate the inferior vena cava, resulting in serious injury to patients. Plaintiffs claim that the devices are defective, and accuse C.R. Bard of failing to adequately warn the medical community and patients about the risks associated with the filters.

Individuals who allegedly experienced serious complications due to C.R. Bard's Recovery and G2 IVC filters may be entitled to compensation for medical bills, lost wages, pain and suffering, and more. To learn more about filing a C.R. Bard IVC filter lawsuit, please visit Bernstein Liebhard LLP's website. Free, no-obligation legal consultations can also be obtained by calling 800-511-5092.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.5 billion on behalf of our clients. The Firm was named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list for a dozen consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.ivcfilterlawsuit2015.com/
https://plus.google.com/115936073311125306742?rel=author